| Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376) |
|---|
| 02/07/2002 | WO2002009694A1 Anticonvulsant derivatives useful for the treatment of depression |
| 02/07/2002 | US20020016473 Enantioselectivity of alpha,beta-unsaturated aldehydes |
| 02/07/2002 | US20020016357 Novel discalamide compounds and their use as anti-proliferative agents |
| 02/07/2002 | CA2417495A1 Methods for treating cell proliferative disorders and viral infections |
| 02/07/2002 | CA2417304A1 Anticonvulsant derivatives useful for the treatment of depression |
| 02/06/2002 | EP1177197A2 Polyamines and their use in therapy |
| 02/06/2002 | EP0771198B1 Dihydro-2,3-benzodiazepine derivatives |
| 01/31/2002 | US20020013483 Process for the preparation of dianhydrohexitol bisacylates |
| 01/31/2002 | US20020013482 Process for the preparation of dianhydrohexitol bis(4-acryloyloxy)acylates |
| 01/31/2002 | US20020013480 Methods for preparing antiviral calanolide compounds |
| 01/31/2002 | US20020013478 Viricides |
| 01/31/2002 | US20020013475 Catalyst for unsaturated carbonyl compounds |
| 01/31/2002 | US20020013380 Photopolymerizable vinyl ether based monomeric formulations and polymerizable compositions which may include certain novel spiroorthocarbonates |
| 01/31/2002 | US20020012683 Cosmetic composition comprising at least one ingredient chosen from compounds of formula (1) and salts thereof, use thereof as colouring agent, and novel compounds of formulae (IIa), (IIIa), (IVa), (Va), and (VIa), and salts thereof |
| 01/30/2002 | EP0836602B1 Fungicidal pyrimidinones |
| 01/30/2002 | CN1333820A Recombinant methods and materials for producing epothilone and eopthilone derivatives |
| 01/30/2002 | CN1333775A Process and products of purification of anhydrosugar alcohol |
| 01/30/2002 | CN1333763A Process for production of an oxetane |
| 01/29/2002 | US6342614 Isomerization of gamma, delta-epoxyalkenes or gamma, delta-epoxycycloalkenes to 2,5-dihydrofurans using catalytic system which comprises onium iodide and lewis acid |
| 01/29/2002 | US6342490 Antiproliferation of cells |
| 01/29/2002 | US6342459 Photochromic naphthopyrans |
| 01/24/2002 | WO2002006264A1 Lipid-rich plaque inhibitors |
| 01/24/2002 | WO2002006245A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof |
| 01/24/2002 | US20020010207 Tropane analogs and methods for inhibition of monoamine transport |
| 01/24/2002 | US20020010206 Treating cyclooxygenase-2 mediated disorders. |
| 01/24/2002 | US20020010204 Use as pesticides. |
| 01/24/2002 | CA2429008A1 Lipid-rich plaque regressing agents |
| 01/24/2002 | CA2384041A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof |
| 01/23/2002 | EP1173451A1 New antioxidative vitamin b 6 analogs |
| 01/23/2002 | EP1173442A2 Methods for preparing antiviral calanolide compounds |
| 01/23/2002 | EP1173441A1 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations |
| 01/23/2002 | EP1173396A1 Singlet oxygen oxidation of organic substrates |
| 01/23/2002 | EP1173223A2 Conjugates as therapies for cancers and prostate diseases |
| 01/23/2002 | EP0833826B1 Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease |
| 01/23/2002 | CN1332742A Epothilone derivatives and their use as antitumor agents |
| 01/22/2002 | US6340765 Photochromic dyes and development |
| 01/22/2002 | US6340671 Stable compositions for parenteral administration and their use |
| 01/17/2002 | WO2002004455A2 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
| 01/17/2002 | WO2002004431A1 Silent mark for oil product and detection method thereto |
| 01/17/2002 | US20020006960 Neuraminidase inhibitors |
| 01/17/2002 | US20020006908 Anticonvulsant derivatives useful in treating schizophrenia |
| 01/17/2002 | US20020006393 Compounds for the photodecontamination of pathogens in blood |
| 01/16/2002 | EP0666891B1 Chemiluminescent electron-rich aryl-substituted 1,2-dioxetanes |
| 01/16/2002 | CN1331675A Novel herbicides |
| 01/16/2002 | CN1331078A 4-beta-amino-saccharidoid side chain-4-dehydro-4'-demethylpodoph-yllotoxin derivative with antineoplastic activity and its synthesizing process |
| 01/16/2002 | CN1077888C Benzopyrans and pharmaceutical compsn. contg. same |
| 01/15/2002 | US6339164 C2 substituted phenyl taxane derivatives and pharmaceutical compositions containing them |
| 01/10/2002 | WO2002002512A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2000061138A8 Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders |
| 01/10/2002 | CA2410651A1 Compounds to treat alzheimer's disease |
| 01/09/2002 | EP1169281A1 Singlet oxygen oxidation of organic substrates |
| 01/09/2002 | EP1169034A1 Decursinol or derivative thereof as analgesic agent |
| 01/09/2002 | EP1119558A4 Continuous process for the production of anhydrosugar alcohols |
| 01/03/2002 | WO2002000663A2 Polycyclic xanthones as antibiotics |
| 01/03/2002 | WO2002000617A2 Selective androgen receptor modulators and methods for their identification, design and use |
| 01/03/2002 | US20020002291 Continuous process for the manufacture of anhydro sugar alcohols and reactor useful therefor |
| 01/03/2002 | US20020002284 Processes and novel intermediates for 11-oxa prostaglandin synthesis |
| 01/03/2002 | US20020002194 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 01/03/2002 | CA2413417A1 Selective androgen receptor modulators and methods for their identification, design and use |
| 01/03/2002 | CA2412559A1 Polycyclic xanthones as antibiotics |
| 01/02/2002 | EP1165627A1 Photopolymerizable vinyl ether based monomeric formulations and polymerizable compositions which may include certain novel spiroorthocarbonates |
| 01/02/2002 | EP1165516A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 01/02/2002 | EP1109789A4 Triptolide prodrugs having high aqueous solubility |
| 01/02/2002 | CN1329611A Phenylacetic acid heterocyclyl amides having an insecticidal effect |
| 01/02/2002 | CN1329607A Substituted benzopyran analogs for treatment of inflammation |
| 01/02/2002 | CN1077110C 13-substituted milbemycin 5-oxime derivatives and compositions and their use |
| 01/01/2002 | US6335364 Tubulin polymerization inhibitors; antiproliferative and antitumor agents |
| 01/01/2002 | US6335353 3-hydroxypyridin-4-one derivative; iron deficiency anemia and thalassemia treatment |
| 12/27/2001 | WO2001098308A1 Process for preparing cyclic polyethers |
| 12/27/2001 | WO2001098307A1 Carbamate and thiocarbamate podophyllotoxin derivatives, preparation method and pharmaceutical compositions containing them |
| 12/27/2001 | WO2001098291A2 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 12/27/2001 | WO2001097769A1 Ferulic ester derivative, 3,9-diferulylcoumestrol and cosmetic product containing same |
| 12/27/2001 | CA2413878A1 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 12/20/2001 | US20010053857 Tricyclic and tetracyclic taxane intermediates |
| 12/19/2001 | EP1163243A2 Calanolides for inhibiting btk |
| 12/19/2001 | EP0983063B1 Pharmaceutical composition containing uscharin |
| 12/19/2001 | CN1326934A 1,7-twice substituted perylene-3,4,9.10-tetracarboxylic acid diimide |
| 12/18/2001 | US6331625 Eyeglass lenses; rapid color and brightness adjustment |
| 12/18/2001 | US6331561 Use of substituted amino-methyl-chromans for the prevention of neuronal degeneration and for the promotion of neuronal regeneration |
| 12/18/2001 | CA2057917C New class of compounds having a variable spectrum of activities for capsaicin-like responses, compositions and uses thereof |
| 12/13/2001 | WO2001094352A1 Method for purifying a composition containing at least an internal dehydration product for a hydrogenated sugar |
| 12/13/2001 | WO2001041709A3 Methods for treating cell death diseases and inflammation |
| 12/13/2001 | WO2001036424A3 Naphthopyrans having a perfluoroalkyl substituent in position 5, preparation and compositions and matrices containing them |
| 12/13/2001 | WO2001027308A3 13-alkyl epothilone derivatives |
| 12/13/2001 | US20010051735 Derivatives of isosorbide mononitrate and its use as vasodilating agents with reduced tolerance |
| 12/12/2001 | EP1161430A2 Epothilon derivatives, method for the production and the use thereof as pharmaceuticals |
| 12/12/2001 | EP0861248B1 Indolealkyl derivatives of benzodioxanmethylamine as 5-ht1a receptor ligands |
| 12/12/2001 | CN1325838A Preparation of resoreinol derivative |
| 12/11/2001 | US6329421 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
| 12/11/2001 | US6329420 2,5 bis(1-hydroxyalkyl)tetrahydrothiopene derivatives; inhibiting polymerization or inducing depolymerization of tubulin; antiproliferation agent |
| 12/11/2001 | US6329364 Crystalline form of dihydro-2,3-benzodiazepine derivative |
| 12/11/2001 | CA2024919C Process for the preparation of 23-(c1-c6 alkyloxime)-ll-f28249 compounds |
| 12/06/2001 | WO2001092266A2 Process for the manufacture of anhydro sugar alcohols |
| 12/06/2001 | WO2001092255A2 Epothilone derivatives and methods for making and using the same |
| 12/06/2001 | WO2001092246A2 Continuous process for the manufacture of anhydro sugar alcohols |
| 12/05/2001 | EP1160325A1 Avermectin aglycon synthase genes |
| 12/05/2001 | EP1159278A2 Inhibitors of aspartyl protease |
| 12/05/2001 | CN1324887A Polyolefin resin composition containing polyolefin resin and nucleation agent |
| 12/05/2001 | CN1075799C Monomers and composition which can be crosslinked and crosslinked polymers |
| 12/04/2001 | US6326494 1,7-Diaroxy- or 1,7-arylthio-substituted perylene-3,4,9,10-tetracarboxylic acids, their dianhydrides and diimides |